CHAMPIONS ONCOLOGY, INC. Payments of Stock Issuance Costs
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Payments of Stock Issuance Costs of $0 for the 12-month period ending 2017-04-30, per its 10-K filed 2017-07-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2020-07-28
- CHAMPIONS ONCOLOGY, INC. payments of stock issuance costs for the quarter ending 2017-04-30 was $0.00.
- CHAMPIONS ONCOLOGY, INC. payments of stock issuance costs for the quarter ending 2017-01-31 was $0.00.
- CHAMPIONS ONCOLOGY, INC. payments of stock issuance costs for the quarter ending 2016-10-31 was $0.00.
- CHAMPIONS ONCOLOGY, INC. payments of stock issuance costs for the quarter ending 2016-07-31 was $0.00, a 100.00% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. payments of stock issuance costs for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- CHAMPIONS ONCOLOGY, INC. payments of stock issuance costs for fiscal 2016 was $18.00K.
- CHAMPIONS ONCOLOGY, INC. payments of stock issuance costs for fiscal 2015 was $0.00.
| Period end | Payments of Stock Issuance Costs | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|---|
| 2017-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $0.00 derived: sum of 2 quarters · filed 2017-07-28 | $0.00 derived: sum of 3 quarters · filed 2017-07-28 | $0.00 10-K · filed 2017-07-28 | |
| 2017-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-17 | $0.00 derived: sum of 2 quarters · filed 2017-03-17 | $0.00 10-Q · filed 2017-03-17 | $0.00 derived: sum of 4 quarters · filed 2017-07-28 | |
| 2016-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-14 | $0.00 10-Q · filed 2016-12-14 | $0.00 derived: sum of 3 quarters · filed 2017-07-28 | $0.00 derived: sum of 4 quarters · filed 2017-07-28 | |
| 2016-07-31 | $0.00 10-Q · filed 2016-09-14 | $0.00 derived: sum of 2 quarters · filed 2017-07-28 | $0.00 derived: sum of 3 quarters · filed 2017-07-28 | $0.00 derived: sum of 4 quarters · filed 2017-07-28 | |
| 2016-06-15 | $742.00K 10-K · filed 2020-07-28 | ||||
| 2016-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $0.00 derived: sum of 2 quarters · filed 2017-07-28 | $0.00 derived: sum of 3 quarters · filed 2017-07-28 | $18.00K 10-K · filed 2017-07-28 | |
| 2016-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-17 | $0.00 derived: sum of 2 quarters · filed 2017-03-17 | $18.00K 10-Q · filed 2017-03-17 | $18.00K derived: sum of 4 quarters · filed 2017-03-17 | |
| 2015-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-14 | $18.00K 10-Q · filed 2016-12-14 | $18.00K derived: sum of 3 quarters · filed 2016-12-14 | $18.00K derived: sum of 4 quarters · filed 2016-12-14 | |
| 2015-07-31 | $18.00K 10-Q · filed 2016-09-14 | $18.00K derived: sum of 2 quarters · filed 2016-09-14 | $18.00K derived: sum of 3 quarters · filed 2016-09-14 | ||
| 2015-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $0.00 derived: sum of 2 quarters · filed 2016-07-29 | $0.00 10-K · filed 2016-07-29 | ||
| 2015-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-16 | $0.00 10-Q · filed 2016-03-16 | |||
| 2014-10-31 | $0.00 10-Q · filed 2015-12-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |